Age-related macular degeneration (AMD) is a common condition causing progressive visual impairment, leading to irreversible blindness. Existing diagnostic tools for AMD are limited to clinical signs of drusen deposition in the macula and the visual assessment of the patient. The presence of circulating microRNAs (miRNAs) in the peripheral circulatory system with potential as diagnostic, prognostic, and/or predictive biomarkers has been reported in a number of conditions/diseases. miRNAs are key regulators of several biological processes, and miRNA dysregulation has been linked with numerous diseases, most remarkably cancer. miRNAs have been shown to be involved in AMD pathology, and several miRNA target genes and signalling pathways were associated with AMD pathogenesis. Exosomes are 50-90 nm membrane microvesicles (MVs), released by several cell types. Although exosomal functions are not completely understood, there is much evidence to suggest that exosomes play an essential role in cell-cell communication. They may stimulate target cells by transferring different bioactive molecules such as miRNA. Here we discuss methods to isolate exosome using serum specimens from AMD patients and miRNA profiling for the better understanding of the disease.
Keywords: Age-related macular degeneration; Atrophic AMD; Exosomes; MicroRNA; Neovascular AMD; Retinal pigment epithelium; Serum.
© 2023. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.